Home Newsfeeds Savara Q2 EPS $(0.06) Up From $(0.07) YoY

Savara Q2 EPS $(0.06) Up From $(0.07) YoY

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Savara (NASDAQ:SVRA) reported quarterly losses of $(0.06) per share. This is a 14.29 percent increase over losses of $(0.07) per share from the same period last year.

Citigroup Maintains Buy on Abbott Laboratories, Raises Price Target to $125

By Benzinga Newsdesk

December 12, 8:56 AM

Citigroup analyst Joanne Wuensch maintains Abbott Laboratories (NYSE:ABT) with a Buy and raises the price target from $114 to $125.

ABT

Oppenheimer Holdings Q4 EPS $1.87 Down From $4.61 YoY, Sales $313.58M Down From $365.12M YoY

By Benzinga Newsdesk

January 27, 9:04 AM

Oppenheimer Holdings (NYSE:OPY) reported quarterly earnings of $1.87 per share. This is a 59.44 percent decrease over earnings of $4.61 per share from the same period last year. The company reported $313.58 million in

OPY

Cidara’s Lower Than Expected Q4 Earnings Overshadows FDA Nod For Antifungal Treatment

By Vandana Singh

March 23, 10:35 AM

The FDA approved Cidara Therapeutics Inc’s (NASDAQ:CDTX) antifungal Rezzayo (rezafungin) under priority review for treating candidemia and invasive candidiasis in adults…

CDTX